Background: How GLP-1s evolved from diabetes treatment to anti-obesity medications Glucagon-like peptide-1 receptor agonists (GLP-1s) have a notable history in medical treatment, beginning as therapies for type 2 diabetes and later emerging as highly effective agents for weight loss
27 Lipoic acid has received research attention for its possible role in preventing and treating hearing loss, and has shown promise in preclinical models of age-related, noise-induced, and ototoxic drug-related hearing loss
The knee ligaments (ACL, PCL, MCL, LCL) that provide knee stability can become lax, especially in advanced stages, causing sensations of giving way, affecting knee alignment and potentially causing bone deformity
The blend draws on two parallel lines of peptide research into growth hormone modulation
Guidance for industry: Immunogenicity assessment for therapeutic protein products
SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies
